Literature DB >> 27417524

Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms.

Anna L Paterson1,2, Pierre Lao-Sirieix1, Maria O'Donovan1,2, Irene Debiram-Beecham1, Massimiliano di Pietro1, Ahmad Miremadi1,2, Stephen E Attwood3, Fiona M Walter4, Peter D Sasieni5, Rebecca C Fitzgerald1.   

Abstract

AIMS: Reflux symptoms are highly prevalent and non-specific; hence, in the absence of alarm symptoms, endoscopy referral decisions are challenging. This study evaluated whether a non-endoscopic Cytosponge could detect benign oesophageal pathologies and thus have future potential in triaging patients with persistent symptoms. METHODS AND
RESULTS: Two complementary cohorts were recruited: (i) patients with reflux symptoms and no prior endoscopy (n = 409), and (ii) patients with reflux symptoms referred for endoscopy (n = 411). All patients were investigated using the Cytosponge and endoscopy. Significant epithelial inflammation was present in 130 (16%) Cytosponge samples, 32 of which had ulcer slough. Candida and significant inflammation was detected in a further 22 (2.3%) cases; epithelial infiltration with >15 eosinophils/high-power field reflecting possible eosinophilic oesophagitis (EOE) in five (0.6%); and viral inclusions suggestive of herpes oesophagitis in one (0.1%). No significant pathology was detected in the majority, 662 (81%), of Cytosponge samples. Cytosponge and endoscopy findings were in agreement in 574 (70%) cases, in 165 (67%) of the discordant cases one investigation showed mild inflammation while the other was negative, with an additional 22 (8.9%) differing on the extent of inflammation. Eighteen cases with severe inflammation, six with candida and two with EOE were detected only at endoscopy, while 18 with candida and significant inflammation, 13 with ulcer slough, one probable EOE and one viral oesophagitis were identified on the Cytosponge only.
CONCLUSIONS: The Cytosponge detects a range of benign oesophageal pathologies, and therefore has potential clinical utility in the triaging of patients with troublesome reflux symptoms. This warrants further investigation.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  endoscopy; gastroesophageal reflux disease; non-invasive screening; oesophagitis

Mesh:

Year:  2016        PMID: 27417524     DOI: 10.1111/his.13039

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.

Authors:  Wladyslaw Januszewicz; Wei Keith Tan; Katie Lehovsky; Irene Debiram-Beecham; Tara Nuckcheddy; Susan Moist; Sudarshan Kadri; Massimiliano di Pietro; Alex Boussioutas; Nicholas J Shaheen; David A Katzka; Evan S Dellon; Rebecca C Fitzgerald
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

Review 2.  Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device-The CytospongeTM.

Authors:  Anna L Paterson; Marcel Gehrung; Rebecca C Fitzgerald; Maria O'Donovan
Journal:  Diagn Cytopathol       Date:  2019-12-09       Impact factor: 1.582

Review 3.  Noninvasive tests for eosinophilic esophagitis: Ready for use?

Authors:  Emily C McGowan; Seema S Aceves
Journal:  Ann Allergy Asthma Immunol       Date:  2021-10-24       Impact factor: 6.248

4.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

5.  Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening.

Authors:  Sarmed S Sami; Prasad G Iyer; Prachi Pophali; Magnus Halland; Massimiliano di Pietro; Jacobo Ortiz-Fernandez-Sordo; Jonathan R White; Michele Johnson; Indra Neil Guha; Rebecca C Fitzgerald; Krish Ragunath
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-03       Impact factor: 11.382

6.  A non-endoscopic device to sample the oesophageal microbiota: a case-control study.

Authors:  Daffolyn R Fels Elliott; Alan W Walker; Maria O'Donovan; Julian Parkhill; Rebecca C Fitzgerald
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-11-12

7.  Endoscopic screening for Barrett's esophagus: while we're in, do we also need to see the stomach and the duodenum?

Authors:  Mihai Ciocîrlan
Journal:  Endosc Int Open       Date:  2017-05

8.  Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study.

Authors:  David A Katzka; Thomas C Smyrk; Jeffrey A Alexander; Debra M Geno; RoseMary A Beitia; Audrey O Chang; Nicholas J Shaheen; Rebecca C Fitzgerald; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2017-08-15       Impact factor: 10.864

9.  Reassessing the value of gastroscopy for the investigation of dyspepsia.

Authors:  Hey-Long Ching; Melissa F Hale; Reena Sidhu; Mark E McAlindon
Journal:  Frontline Gastroenterol       Date:  2017-08-05

10.  Organ-preserving approaches in oesophageal cancer.

Authors:  Rebecca C Fitzgerald
Journal:  Lancet Oncol       Date:  2018-06-01       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.